Attachment and Substance Use Disorders—Theoretical Models, Empirical Evidence, and Implications for Treatment

The Role of Negative Affect in the Course of Substance Use Disorders

10.1093/oso/9780190499037.003.0014 ◽

2018 ◽

Author(s):

Elizabeth D. Reese ◽

Jennifer Y. Yi ◽

Ryan P. Bell ◽

Stacey B. Daughters

Keyword(s):

Substance Use ◽

Negative Affect ◽

Substance Use Disorders ◽

Substance Use Disorder ◽

Theoretical Models ◽

Central Mechanism ◽

Substance Use Treatment ◽

Increased Risk ◽

The Impact

Negative affect (NA) plays a prominent role in theoretical models characterizing the course of substance use disorders and is thus considered a central mechanism contributing to maintenance of symptoms and increased risk for relapse. This chapter overviews theoretical models of substance use, highlighting the impact of NA within the addiction cycle. In this context, it examines the evidence linking NA to substance use disorder (SUD) development, maintenance, and relapse, highlighting the association between NA and addiction-specific processes including withdrawal and craving. It concludes with a discussion of current substance use treatment approaches that target NA, including promising new pharmacological and neurobiological treatments.

Download Full-text

Eating Disorders

10.1093/oxfordhb/9780199797004.013.017 ◽

2014 ◽

Author(s):

Pamela K. Keel ◽

Lauren A. Holland

Keyword(s):

Eating Disorders ◽

Substance Use ◽

Substance Use Disorders ◽

Twin Studies ◽

Theoretical Models ◽

Elevated Risk ◽

Treatment Seeking ◽

Model Data ◽

Comorbid Depression ◽

The Common

This chapter examines patterns of comorbidity between eating disorders and mood, anxiety, and substance use disorders along with evidence regarding support for different theoretical models that may account for these patterns. Although comorbidity estimates may be inflated by reliance on treatment-seeking samples and double counting of symptoms that overlap between syndromes, evidence supports elevated risk of mood, anxiety, and substance use disorders in anorexia nervosa, bulimia nervosa, and binge eating disorder. Data from family and twin studies support that eating and anxiety disorders may have a shared diathesis, consistent with the common cause model. Data from longitudinal studies suggest that eating disorders may increase vulnerability for developing a substance use disorder, consistent with the predisposition model. In contrast, comorbidity between eating and mood disorders, such as depression, remains poorly understood. Clinical issues regarding comorbidity of depression and eating disorders along with guidelines for clinicians treating patients with comorbid depression and eating disorders are discussed.

Download Full-text

Psychosocial Treatments for People with Co-occurring Severe Mental Illnesses and Substance Use Disorders (Dual Diagnosis): A Review of Empirical Evidence

Harvard Review of Psychiatry ◽

10.1080/10673220902724599 ◽

2009 ◽

Vol 17 (1) ◽

pp. 24-34 ◽

Cited By ~ 132

Author(s):

Jan Horsfall ◽

Michelle Cleary ◽

Glenn E. Hunt ◽

Garry Walter

Keyword(s):

Substance Use ◽

Empirical Evidence ◽

Substance Use Disorders ◽

Dual Diagnosis ◽

Mental Illnesses ◽

Psychosocial Treatments

Download Full-text

Comorbidity of Anxiety and Depression with Substance Use Disorders

10.1093/oxfordhb/9780199381708.013.19 ◽

2014 ◽

Cited By ~ 1

Author(s):

Sherry Stewart ◽

Valerie V. Grant ◽

Clare J. Mackie ◽

Patricia J. Conrod

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Depressive Disorders ◽

Experimental Studies ◽

Theoretical Models ◽

Epidemiologic Studies ◽

Research Literature ◽

Anxiety And Depression ◽

Research Attention ◽

Drug Use Disorders

The comorbidity of substance use disorders (SUDs) with anxiety and depression is the focus of substantial research attention and approached from myriad perspectives. This chapter focuses on the resultant complex research literature, first providing an overview of epidemiologic studies that have examined the prevalence of co-occurrence of SUDs (including alcohol and other drug use disorders) with anxiety and depressive disorders, as well as clinical correlates of these forms of comorbidity. Next, theoretical models of the onset and maintenance of emotional disorder–SUD comorbidity are considered, followed by a review of various types of studies evaluating these theoretical models (studies focusing on order-of-onset, the independent versus substance-induced disorder distinction, self-reported motives for use, genetic epidemiology, and experimental studies). Distinctions and commonalities between anxiety–SUD associations and depression–SUD associations are examined throughout. The chapter concludes by examining treatment implications of this comorbidity and suggests future directions for this burgeoning field.

Download Full-text